A clinical study of BRIMOCHO
Latest Information Update: 06 Oct 2020
Price :
$35 *
At a glance
- Drugs VTI-001 (Primary)
- Indications Presbyopia
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2020 New trial record
- 28 Sep 2020 Results presented in the Visus Therapeutics Media Release.